Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$289K Buy
+2,595
New +$307K ﹤0.01% 1881
2025
Q4
Sell
-3,633
Closed -$308K 1606
2025
Q3
$308K Buy
+3,633
New +$223K ﹤0.01% 1611

Other funds holding ABVX

Integrated Wealth Concepts's ABVX Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in Abivax (ABVX) in Q1 2026: 2,595 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #1881 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in ABVX as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in ABVX in Q3 2025 and has held it in 2 quarters since. The position peaked at $308K in Q3 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Integrated Wealth Concepts held 2,595 shares of Abivax worth $289K as of Q1 2026.
  • Abivax was a new Integrated Wealth Concepts position in Q1 2026.
  • Abivax made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #1881 holding.
  • Integrated Wealth Concepts first reported a position in Abivax in Q3 2025 and has held it in 2 quarters since.
  • Integrated Wealth Concepts's Abivax position peaked at $308K in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.